Center for Substance Abuse Treatment; Notice of Meeting, 40602-40603 [E9-19242]

Download as PDF 40602 Federal Register / Vol. 74, No. 154 / Wednesday, August 12, 2009 / Notices TABLE 1—ESTIMATES OF ANNUALIZED HOUR BURDEN TO RESPONDENTS—Continued Instrument type Burden per response (hrs.) Respondent Community-Level Burden Cohorts 3 and 4 CLI Part I, 21–172: Community SPF Activities (Reporting Year 1). CLI Part II (Reporting Year 1) .......... CLI Part I, 21–172: Community SPF Activities (Reporting Years 2–4). CLI Part II (Reporting Years 2–4) ..... Total burden Over 4 Reporting Periods. Average Annual Burden .................... No. of respondents No. of responses per respondent Total burden (hrs.) Community ....................................... 3 540 1 1620.0 Community ....................................... Community ....................................... 0.75 0.75 540 540 6 3 2,430.0 1,215 Community ....................................... Community ....................................... 0.5 ........................ 540 ........................ 18 ........................ 4,860.0 10,125.0 Community ....................................... ........................ ........................ ........................ 2,531.25 Total Burden All Cohorts Total Burden Over 4 Reporting Years. ........................................................... Average Annual Burden .................... Grantee ............................................ ........................ ........................ ........................ 485.0 Community ....................................... Grantee ............................................ Community ....................................... Overall .............................................. ........................ ........................ ........................ ........................ ........................ ........................ ........................ ........................ ........................ ........................ ........................ ........................ 21,998.1 121.3 5,499.6 5,620.8 Written comments and recommendations concerning the proposed information collection should be sent by September 11, 2009 to: SAMHSA Desk Officer, Human Resources and Housing Branch, Office of Management and Budget, New Executive Office Building, Room 10235, Washington, DC 20503; due to potential delays in OMB’s receipt and processing of mail sent through the U.S. Postal Service, respondents are encouraged to submit comments by fax to: 202–395– 6974. Dated: August 6, 2009. Elaine Parry, Director, Office of Program Services. [FR Doc. E9–19291 Filed 8–11–09; 8:45 am] BILLING CODE 4162–20–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health jlentini on DSKJ8SOYB1PROD with NOTICES National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning VerDate Nov<24>2008 16:38 Aug 11, 2009 Jkt 217001 individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Infectious Diseases Clinical Studies and Trails. Date: September 16, 2009. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate contract proposals. Place: Crowne Plaza Hotel—Silver Spring, 8777 Georgia Avenue, Silver Spring, MD 20910. Contact Person: Edward W. Schroder, PhD, Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, NIAID, NIH, Room 2156, 6700–B Rockledge Drive, MSC 7616, Bethesda, MD 20892–7616, 301–496–2550. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: August 5, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–19320 Filed 8–11–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Center for Substance Abuse Treatment; Notice of Meeting Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Substance Abuse Treatment (CSAT) National Advisory Council will meet on August 24, 2009 from 1 p.m. to 3 p.m. via teleconference. The meeting will include discussion and evaluation of grant applications reviewed by Initial Review Groups. Therefore, the meeting will be closed to the public as determined by the Administrator, SAMHSA, in accordance with Title 5 U.S.C. 552b(c)(6) and 5 U.S.C. App. 2, section 10(d). Substantive program information, a summary of the meeting and a roster of Council members may be obtained as soon as possible after the meeting, either by accessing the SAMHSA Committee Web site at https://www.nac.samhsa.gov, or by contacting CSAT National Advisory Council’s Designated Federal Official, Ms. Cynthia Graham (see contact information below). Committee Name: SAMHSA Center for Substance Abuse Treatment National Advisory Council. Dates/Times/Types: August 24, 2009, from 1 p.m. to 3 p.m.: Closed. Place: SAMHSA Building, 1 Choke Cherry Road, Great Falls Room, Rockville, Maryland 20857. Contact: Cynthia Graham, M.S., Designated Federal Official, SAMHSA CSAT National Advisory Council, 1 Choke Cherry Road, Room 5–1035, Rockville, Maryland 20857. Telephone: (240) 276–1692. Fax: (240) 276– Pursuant to Public Law 92–463, notice is hereby given that the PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 E:\FR\FM\12AUN1.SGM 12AUN1 Federal Register / Vol. 74, No. 154 / Wednesday, August 12, 2009 / Notices 1690. E-mail: cynthia.graham@samhsa.hhs.gov. Toian Vaughn, Committee Management Officer, Substance Abuse and Mental Health Services Administration. [FR Doc. E9–19242 Filed 8–11–09; 8:45 am] Dated: August 4, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–19090 Filed 8–11–09; 8:45 am] BILLING CODE 4140–01–M BILLING CODE 4162–20–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health National Center for Complementary & Alternative Medicine; Amended Notice of Closed Meeting National Institute of General Medical Sciences; Notice of Closed Meeting jlentini on DSKJ8SOYB1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of General Medical Sciences; Special Emphasis Panel ARRA Funds—Competitive Supplement. Date: August 19, 2009. Time: 1 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Natcher Building, Room 3AN18, 45 Center Drive, Bethesda, MD 20892. (Telephone Conference Call) Contact Person: John J. Laffan, Ph.D., Scientific Review Officer, Office of Scientific Review, National Institute of General Medical Sciences, National Institutes of Health, Natcher Building, Room 3AN18J, Bethesda, MD 20892, 301–594–2773. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.375, Minority Biomedical Research Support; 93.821, Cell Biology and Biophysics Research; 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.862, Genetics and Developmental Biology Research; 93.88, Minority Access to Research Careers; 93.96, Special Minority Initiatives; 93.701, ARRA Related Biomedical Research and Research Support Awards, National Institutes of Health, HHS). VerDate Nov<24>2008 16:38 Aug 11, 2009 Jkt 217001 Notice is hereby given of a change in the meeting of the National Advisory Council for Complementary and Alternative Medicine, September 11, 2009, 8:30 a.m. to September 11, 2009, 4 p.m., National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 which was published in the Federal Register on July 20, 2009, 74 FR 17204. This meeting is being amended to change the meeting date to September 10, 2009 through September 11, 2009 and the time of the closed session on September 11, 2009. On September 10, 2009 the meeting will be held in open session from 8:30 a.m. to 5 p.m. at the Marriott Bethesda North Hotel & Conference Center, 5701 Marinelli Road, Bethesda, MD 20852. On September 11, 2009 there will be an open session from 8:30 a.m. to 10 a.m. The closed session is scheduled from 10 a.m. to 12 p.m., and the open session will resume from 1 p.m. to 3 p.m. The location for September 11, 2009 remains the same. Dated: August 5, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–19323 Filed 8–11–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center for Research Resources; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 40603 property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Research Resources Special Emphasis Panel. ARRA STRB September Meeting 1. Date: September 8–11, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Bethesda, MD 20892. (Virtual Meeting). Contact Person: Mohan Viswanathan, PhD, Scientific Review Officer, National Center for Research Resources, National Institutes of Health, One Democracy Plaza, 6701 Democracy Blvd., Room 1084, Bethesda, MD 20892–4874. 301–435–0829. mv10f@nih.gov. Name of Committee: National Center for Research Resources Special Emphasis Panel. ARRA STRB September Meeting 2. Date: September 8–11, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Bethesda, MD 20892. (Virtual Meeting). Contact Person: Mohan Viswanathan, PhD, Scientific Review Officer, National Center for Research Resources, National Institutes of Health, One Democracy Plaza, 6701 Democracy Blvd., Room 1084, Bethesda, MD 20892–4874. 301–435–0829. mv10f@nih.gov. Name of Committee: National Center for Research Resources Special Emphasis Panel. ARRA STRB September Meeting 3. Date: September 8–11, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Bethesda, MD 20892. (Virtual Meeting). Contact Person: Carol Lambert, PhD, Scientific Review Officer, Office of Review, National Institutes of Health, NCRR, 6701 Democracy Blvd., 1 Democracy Plaza, Room 1076, MSC 4874, Bethesda, MD 20892. (301)– 435–0814. lambert@mail.nih.gov. Name of Committee: National Center for Research Resources Special Emphasis Panel. ARRA STRB September Meeting 4. Date: September 8–11, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Bethesda, MD 20892. (Virtual Meeting). Contact Person: Carol Lambert, PhD, Scientific Review Officer, Office of Review, National Institutes of Health, NCRR, 6701 Democracy Blvd., 1 Democracy Plaza, Room 1076, MSC 4874, Bethesda, MD 20892. (301)– 435–0814. lambert@mail.nih.gov. E:\FR\FM\12AUN1.SGM 12AUN1

Agencies

[Federal Register Volume 74, Number 154 (Wednesday, August 12, 2009)]
[Notices]
[Pages 40602-40603]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-19242]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Center for Substance Abuse Treatment; Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given that the 
Substance Abuse and Mental Health Services Administration (SAMHSA) 
Center for Substance Abuse Treatment (CSAT) National Advisory Council 
will meet on August 24, 2009 from 1 p.m. to 3 p.m. via teleconference.
    The meeting will include discussion and evaluation of grant 
applications reviewed by Initial Review Groups. Therefore, the meeting 
will be closed to the public as determined by the Administrator, 
SAMHSA, in accordance with Title 5 U.S.C. 552b(c)(6) and 5 U.S.C. App. 
2, section 10(d).
    Substantive program information, a summary of the meeting and a 
roster of Council members may be obtained as soon as possible after the 
meeting, either by accessing the SAMHSA Committee Web site at https://www.nac.samhsa.gov, or by contacting CSAT National Advisory Council's 
Designated Federal Official, Ms. Cynthia Graham (see contact 
information below).

    Committee Name: SAMHSA Center for Substance Abuse Treatment 
National Advisory Council.
    Dates/Times/Types: August 24, 2009, from 1 p.m. to 3 p.m.: 
Closed.
    Place: SAMHSA Building, 1 Choke Cherry Road, Great Falls Room, 
Rockville, Maryland 20857.
    Contact: Cynthia Graham, M.S., Designated Federal Official, 
SAMHSA CSAT National Advisory Council, 1 Choke Cherry Road, Room 5-
1035, Rockville, Maryland 20857. Telephone: (240) 276-1692. Fax: 
(240) 276-

[[Page 40603]]

1690. E-mail: cynthia.graham@samhsa.hhs.gov.

Toian Vaughn,
Committee Management Officer, Substance Abuse and Mental Health 
Services Administration.
[FR Doc. E9-19242 Filed 8-11-09; 8:45 am]
BILLING CODE 4162-20-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.